West Lafayette, IN, United States of America

Pravin Gagare

USPTO Granted Patents = 13 (Patent Applications = 5)

EPO Patents = 4 (Patent Applications = 6)

Average Co-Inventor Count = 2.7

ph-index = 5

Forward Citations = 80(Granted Patents)

Company Filing History:

11 out of 15

On Target Laboratories, LLC

patents

1 out of 2,668

Purdue Research Foundation

patents

1 out of 832,912

Other

patents

Years Active: 2016-2024

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12144874 - Synthesis and composition of photodynamic therapeutic agents for the targeted treatment of cancer (2024-11-19),

2. 11964965 - Methods of manufacture and synthesis of fluorescent dye compounds and uses thereof (2024-04-23),

3. 10786580 - Cholecystokinin 2 receptor targeted NIR imaging and use thereof (2020-09-29),

4. 10746741 - CA IX—NIR dyes and their uses (2020-08-18),

5. 10676487 - Synthesis and composition of photodynamic therapeutic agents for the targeted treatment of cancer (2020-06-09),

6. 10557854 - CA IX—NIR dyes and their uses (2020-02-11),

7. 10456482 - PSMA—targeted NIR dyes and their uses (2019-10-29),

8. 10308606 - PSMA-targeted NIR dyes and their uses (2019-06-04),

9. 9968691 - PSMA-targeted NIR dyes and their uses (2018-05-15),

10. 9808538 - PSMA-targeted NIR dyes and their uses (2017-11-07),

11. 9801956 - PSMA-targeted NIR dyes and their uses (2017-10-31),

12. 9534002 - Procedures for the synthesis of ethylenediamine bisborane and ammonia borane (2017-01-03),

13. 9254341 - Methods of manufacture of pteroyl-amino acid-fluorescent dyes (2016-02-09),

Title: Pravin Gagare: Innovator in Photodynamic Therapy and Diagnostic Imaging

Introduction

Pravin Gagare is a notable inventor based in West Lafayette, Indiana, recognized for his contributions to the fields of photodynamic therapy and diagnostic imaging. With a total of 13 patents to his name, Gagare has made significant strides in developing innovative solutions for cancer treatment and imaging technologies.

Latest Patents

Gagare's latest patents include groundbreaking work on the synthesis and composition of photodynamic therapeutic agents for the targeted treatment of cancer. This invention describes new compounds that are useful for image-guided surgery and photodynamic therapy. The compounds can be targeted to the nucleus or mitochondria after being delivered to diseased tissues, such as cancer, using a ligand that targets receptors expressed on the diseased tissue. This method allows for effective activity against cancer cells and other disorders. Another significant patent involves methods and compositions for the manufacture and synthesis of fluorescent dye compounds. This disclosure relates to synthesizing and utilizing fluorescent dye compounds or pharmaceutically acceptable salts thereof. The conjugation of amino acid groups to the fluorescent dyes increases specificity and detection of the compound, with methods of manufacture and synthesis contemplated for use in diagnostic imaging.

Career Highlights

Throughout his career, Gagare has worked with various companies, including On Target Laboratories, LLC. His innovative work has positioned him as a key figure in the development of therapeutic and diagnostic solutions.

Collaborations

Gagare has collaborated with notable colleagues, including Sumith A Kularatne and Carrie H Myers, contributing to the advancement of his research and inventions.

Conclusion

Pravin Gagare's contributions to photodynamic therapy and diagnostic imaging exemplify the impact of innovation in healthcare. His patents reflect a commitment to improving treatment options for cancer and enhancing diagnostic capabilities.

This text is generated by artificial intelligence and may not be accurate.